Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitoxantrone Liposome vs Mitoxantrone in Advanced Breast Cancer
NCT02596373Phase 2Unknown
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology
- Start
- Jun 2015
- Primary completion
- Jan 2018
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of mitoxantrone-liposome in breast cancer, sponsored by CSPC ZhongQi Pharmaceutical Technology. Status: unknown.
02
Drugs
mitoxantrone-liposome
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02596373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02596373.